Sign In
Buy WVE
$5.76
+0.0700 (+1.23%)
At Close: Jun 03, 2026
Wave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI HealthCONx Conference
08:30am, Wednesday, 22'nd Nov 2023
CAMBRIDGE, Mass., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling d
Wave Life Sciences Ltd. (WVE) Q3 2023 Earnings Call Transcript
12:04pm, Friday, 10'th Nov 2023
Wave Life Sciences Ltd. (NASDAQ:WVE ) Q3 2023 Earnings Conference Call November 9, 2023 8:30 AM ET Company Participants Kate Rausch - Vice President, Investor Relations & Corporate Affairs Paul Bolno
Wave Life Sciences (WVE) Soars 8.7%: Is Further Upside Left in the Stock?
07:31am, Friday, 29'th Sep 2023
Wave Life Sciences (WVE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price in
Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference
08:30am, Monday, 25'th Sep 2023
CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling
2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss
09:37am, Tuesday, 19'th Sep 2023
Gene-editing therapies are among the most powerful medicines to ever exist. Wave Life Sciences is taking aim at two rare diseases, but it's short on cash.
Wave Life Sciences: Excellent Early Data, Major Collaborations, Needs Cash
05:09pm, Tuesday, 12'th Sep 2023
Wave Life Sciences Ltd. develops stereopure oligonucleotides targeting disease-causing genetic mutations. The company has lead assets in phase 1/2 trials for Duchenne muscular dystrophy and Huntington
Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08:30am, Wednesday, 06'th Sep 2023
CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling
WAVE Life Sciences Ltd. Sees a 23% Stock Price Surge Over the Past Three Months
10:13am, Wednesday, 23'rd Aug 2023
WAVE Life Sciences Ltd. ( WVE , Financial), a preclinical biopharmaceutical company, has seen a significant increase in its stock price over the past three months.
Wave Life Sciences Ltd. (WVE) Q2 2023 Earnings Call Transcript
03:14am, Sunday, 06'th Aug 2023
Wave Life Sciences Ltd. (NASDAQ:WVE ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Kate Rausch - Head of Investor Relations Paul Bolno - President and Chief Executiv
Wave Life Sciences (WVE) Reports Q2 Loss, Tops Revenue Estimates
10:31am, Thursday, 03'rd Aug 2023
Wave Life Sciences (WVE) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.62 per share a year ago.
Wave Life Sciences: Less Certainty On Clinical Programs (Rating Downgrade)
10:00am, Wednesday, 21'st Jun 2023
Wave Life Sciences: Less Certainty On Clinical Programs (Rating Downgrade)
Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates
10:40am, Wednesday, 03'rd May 2023
Wave Life Sciences (WVE) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of $0.06. This compares to loss of $0.62 per share a year ago.
Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days
08:00am, Wednesday, 29'th Mar 2023
CAMBRIDGE, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battl
Wave Life Sciences (WVE) Reports Q4 Loss, Misses Revenue Estimates
09:57am, Wednesday, 22'nd Mar 2023
Wave Life Sciences (WVE) delivered earnings and revenue surprises of -11.90% and 47.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023
08:30am, Thursday, 02'nd Mar 2023
CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battl
